Switzerland Innovation Park Basel Area offers glimpse into the future
The Switzerland Innovation Park Basel Area offers an insight into its activities. The future home of the Park will be presented in a new showroom. Scientists from the University of Basel will also be presenting their latest developments here.
GRID Campus of Collaoration @Showroom Switzerland Innovation Park Basel Area in Allschwil
From mid-2022, the Switzerland Innovation Park Basel Area will be leasing a total of 6,000m2 in the GRID complex for innovation and commerce, which is currently under construction. The new showroom of the Switzerland Innovation Park Basel Area opening this Thursday will allow visitors to see a model of the new GRID building, the GRID Campus of Collaboration. On 50,000m2, this will provide space for research and innovation in the fields of life sciences, biotech, public health and medtech.
The building was designed by Basel architecture firm Herzog & de Meuron and will be constructed by Senn Resources AG. Both companies have backed the creation of the showroom, alongside Economic Development Baselland and BaselArea.swiss, which operates the Switzerland Innovation Park Basel Area. The Department of Biomedical Engineering (DBE) at the University of Basel has also been involved. It will use the showroom to present its “latest developments in the areas of robotics, laser technology and virtual reality”. In addition, visitors will find information about the work of the Switzerland Innovation Park Basel Area and the startups that will be based there. They will therefore gain a comprehensive insight into the future of the life sciences cluster Allschwil.
The showroom is located on the ground floor of Gewerbestrasse 12 in Allschwil. It is open to all, though registration is required. In future, events will also take place in the showroom.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More
The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.Read More